Disseminated Intravascular Coagulation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Study Population: All adult patients admitted to the ICU for more than 24 hours at the Sixth Affiliated Hospital of Sun Yat-sen University from January 2021 to January 2024. As this is a retrospective study, informed consent was waived. Inclusion Criteria: 1.Patients aged 18 years or older. 2.Hospitalization for at least 72 hours. 3.ICU treatment for a minimum of 24 hours.
Exclusion criteria
Exclusion criteria: 1.Patients with previous ICU admissions (i.e., those not admitted to the ICU for the first time). 2.Patients with an anticipated survival time of =72 hours. 3.Patients whose incomplete clinical data could affect the study. 4.Patients with hematologic malignancies. 5.Patients aged <18 years. 6.Patients who received antiplatelet and/or anticoagulant therapy within one month prior to ICU admission. 7.Patients admitted solely for diagnostic examinations or hemodialysis. 8.Patients admitted for the treatment of venous thromboembolism (VTE). 9.Patients hospitalized due to chronic illnesses rather than acute internal medical conditions. 10.Patients who explicitly refuse participation in any research and decline the use of their hospitalization information upon admission.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 30-day survival; | — |
Countries
China
Contacts
The Sixth Affiliated Hospital of Sun Yat-Sen University